Thalidomide-C2-amido-C2-COOH - HY-130713
Nur noch %1 verfügbar
Catalog #
HY-130713
Ab
88,00 €
Thalidomide-C2-amido-C2-COOH incorporates a CRBN ligand for the E3 ubiquitin ligase, and a linker. Thalidomide-C2-amido-C2-COOH can be used to design PROTAC CDK2/9 Degrader-1 (HY-130709)[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-130713/Thalidomide-C2-amido-C2-COOH-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| CAS | 2353496-84-9 |
| Storage | -20°C, 3 years (Powder) |
| MWT | 416.38 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Apoptosis;Autophagy;E3 Ligase Ligand-Linker Conjugates |
| Application: | Cancer-programmed cell death |
|---|